Received Dec 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | 1957405 | — |
no side effects or symptoms were reported; patient received an expired dose of GARDASIL 9,; This spontaneous report was received from a medical student and refers to a 22-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 24-Nov-2024, the patient received an expiry dose of Human Papillomavirus 9-valent Vaccine, Recombinant Injection (GARDASIL 9) (lot #1957405, expiration date: 11-Nov-2025) 0.5 mL for prophylaxis (Expired product administered). No side effects or symptoms were reported.